Alisa Lask - 05 Jul 2023 Form 4 Insider Report for RVL Pharmaceuticals plc (RVLP)

Role
Director
Signature
/s/ Brian Markison, as attorney-in-fact
Issuer symbol
RVLP
Transactions as of
05 Jul 2023
Net transactions value
$0
Form type
4
Filing time
11 Jul 2023, 21:15:22 UTC
Previous filing
09 Jan 2023
Next filing
14 Aug 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Award $0 +40,000 +47% $0.000000 124,557 05 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units.

Remarks:

Exhibit 24.1 - Power of Attorney